Brain Neurotherapy Bio, Inc.
Clinical trials sponsored by Brain Neurotherapy Bio, Inc., explained in plain language.
-
Doctors test gene therapy to protect brain cells in Parkinson's patients
Disease control OngoingThis early-stage study is testing the safety of a one-time gene therapy for Parkinson's disease. The therapy aims to deliver a protective protein (GDNF) directly into a specific brain region to support the cells affected by the disease. The study involves 11 participants with Par…
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC
-
Brain gene therapy tested for devastating neurological disease
Disease control OngoingThis is a very early-stage safety study testing a new gene therapy for multiple system atrophy (MSA), a rare and progressive brain disorder. The therapy, called AAV2-GDNF, is delivered directly into a part of the brain called the putamen. The main goal is to see if the treatment …
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC